Rating #119
John Hussman
Hussman Strategic Advisors
Portfolio value
Stocks
Performance
1 Year
+14.91%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
John Hussman’s Portfolio: Q4 2025
Top10 stocks: 9.94% of the portfolio
John Hussman’s Trades: Q4 2025
Adds
New Buys
Sold Outs
Cuts
0.94ppt
0.81ppt
0.61ppt
0.64ppt
0.52ppt
0.52ppt
0.56ppt
0.44ppt
0.42ppt
0.23ppt
Company Name | Share Count Chg. (%) | Price Paid | Buy Value | Portfolio % Change | |
|---|---|---|---|---|---|
1  CHKP | Add +100.00% | $193.34 | $4.06M | 0.94ppt | |
2  CVS | Add +100.00% | $78.84 | $3.31M | 0.81ppt | |
3  ALNY | Add +100.00% | $442.56 | $2.79M | 0.61ppt | |
4  SBUX | Add +100.00% | $84.36 | $2.66M | 0.64ppt | |
5  UI | Add +100.00% | $632.60 | $2.66M | 0.52ppt | |
6  ETSY | Add +100.00% | $61.02 | $2.56M | 0.52ppt | |
7  GHC | Add +100.00% | $1068.78 | $2.24M | 0.56ppt | |
8  EBAY | Add +100.00% | $86.57 | $1.82M | 0.44ppt | |
9  CNXC | Add +100.00% | $40.57 | $1.70M | 0.42ppt | |
10  TEM | Add +100.00% | $78.23 | $1.64M | 0.23ppt |
John Hussman’s Holdings: Q4 2025
Company Name | Primary Industry | Avg. price paid  | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1  QCOM | Broadcasting Equipment | $171.05 | New Buy +100.00% | 27.30K | $4.67M | 1.13% 1.13ppt | 0.00% | 1 Quarter | Q4 2025 | |
2 ETSY | Other Business Services | $54.83 | Add +100.00% | 84.00K | $4.66M | 1.13% 0.52ppt | 0.08% | 3 Quarters | Q4 2025 | |
3 UI | Broadcasting Equipment | $444.43 | Add +100.00% | 8.40K | $4.65M | 1.12% 0.52ppt | 0.01% | 26 Quarters | Q4 2025 | |
4  UNFI | Wholesale-Grocery Line | $26.02 | Cut -20.00% | 126.00K | $4.24M | 1.03% -0.26ppt | 0.21% | 23 Quarters | Q4 2025 | |
5  CHTR | Cable & Pay TV Services | $356.72 | 0.00% | 18.90K | $3.95M | 0.95% -0.17ppt | 0.01% | 4 Quarters | Q3 2025 | |
6  G | Management Consulting | $44.01 | 0.00% | 84.00K | $3.93M | 0.95% 0.19ppt | 0.05% | 3 Quarters | Q2 2025 | |
7  ACAD | Pharmaceutical Pres | $22.11 | Add +16.67% | 147.00K | $3.93M | 0.95% 0.37ppt | 0.09% | 2 Quarters | Q4 2025 | |
8 CHKP | Prepackaged Software | $185.56 | Add +100.00% | 21.00K | $3.90M | 0.94% 0.94ppt | 0.02% | 6 Quarters | Q4 2025 | |
9  EXEL | Biological products | $27.84 | Cut -20.00% | 84.00K | $3.68M | 0.89% -0.05ppt | 0.03% | 26 Quarters | Q4 2025 | |
10  HALO | Biological products | $54.40 | Add +66.67% | 52.50K | $3.53M | 0.85% 0.35ppt | 0.04% | 15 Quarters | Q4 2025 | |
11 CNXC | Other Business Services | $43.87 | Add +100.00% | 84.00K | $3.49M | 0.84% 0.42ppt | 0.13% | 4 Quarters | Q4 2025 | |
12  NUTX | Other Business Services | $164.62 | New Buy +100.00% | 21.00K | $3.46M | 0.84% 0.84ppt | 0.31% | 1 Quarter | Q4 2025 | |
13 CVS | Retail-Drug Stores | $79.36 | Add +100.00% | 42.00K | $3.33M | 0.81% 0.81ppt | 0.00% | 17 Quarters | Q4 2025 | |
14  SEZL | Other Business Services | $75.04 | Add +38.89% | 52.50K | $3.33M | 0.81% 0.15ppt | 0.15% | 4 Quarters | Q4 2025 | |
15  CL | Perfumes & Cosmetics | $88.85 | 0.00% | 42.00K | $3.32M | 0.80% 0.08ppt | 0.01% | 20 Quarters | Q3 2025 | |
16  PCRX | Pharmaceutical Pres | $25.79 | Add +20.00% | 126.00K | $3.26M | 0.79% 0.20ppt | 0.29% | 2 Quarters | Q4 2025 | |
17  PGNY | Misc. Health Services | $22.21 | Add +20.00% | 126.00K | $3.24M | 0.78% 0.29ppt | 0.15% | 2 Quarters | Q4 2025 | |
18  URBN | Retail-Family Clothing | $72.39 | Add +33.33% | 42.00K | $3.16M | 0.76% 0.28ppt | 0.05% | 2 Quarters | Q4 2025 | |
19  TR | Confectionery | $36.63 | New Buy +100.00% | 84.00K | $3.08M | 0.74% 0.74ppt | 0.12% | 1 Quarter | Q4 2025 | |
20  NEM | Gold & Silver Mining | $48.57 | Cut -40.20% | 30.50K | $3.05M | 0.74% -0.20ppt | 0.00% | 60 Quarters | Q4 2025 |
NEWSLETTER
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersOur content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.